Summary Paragangliomas (glomus tumours) are benign, hypervascular tumours which in general are treated by surgical excision. The indication for treatment of these often slow-growing tumours needs additional criteria for predicting tumour progressiveness. For Paragangliomas (syn.: glomus tumours, chemodectomas) are rare benign hypervascular tumours originating from the tiny glomus bodies which are present throughout the body. In the head and neck area these tumours are mostly found at specific locations. The most common types, in order of frequency, are the carotid body tumour, the glomus jugulare tumour, and the vagal body tumour.
Paragangliomas (syn.: glomus tumours, chemodectomas) are rare benign hypervascular tumours originating from the tiny glomus bodies which are present throughout the body. In the head and neck area these tumours are mostly found at specific locations. The most common types, in order of frequency, are the carotid body tumour, the glomus jugulare tumour, and the vagal body tumour.
Paragangliomas can also present as an autosomal dominant hereditary disease for which, as we showed recently, genomic imprinting may account for the finding that the inheritance is almost exclusively via the paternal line (van der Mey et al., 1989) . Familial paragangliomas are often multicentric, whether uni-or bilateral (van Gils et al., 1990) . The neoplastic nature of paragangliomas has been a subject of debate (Chedid & Jao, 1974; Stiller et al., 1975) . According to some authors, carotid body tumours are due to hyperplasia. In Peruvians living at high altitudes the glomus bodies are larger and heavier than in those dwelling at sea level, possibly due to hyperplasia of parynchymal tissue in response to lower P02 levels (Saldana et al., 1973; Arias-Stella & Valcarcel, 1973) . Others believe that the transformation of a carotid body into a carotid body tumour is due to neoplasia, because they found residual normal paraganglionic tissue outside the tumour capsule (Grimley & Glenner, 1967; Lack et al., 1979) .
The morbidity caused by paragangliomas is not related solely to the highly variable growth pattern, but also to the mode of treatment applied. Surgical excision, where feasible, is considered to be the treatment of choice (Rosenwasser, 1973; Brackmann, 1988) . For the glomus jugulare tumours invading the skull base and sometimes the posterior and middle fossa such surgical resection is a major intervention, frequently resulting in considerable and permanent cranial nerve palsy.
In general, the growth pattern of these neuro-endocrine tumours is characterised by extremely slow progression and in such cases it is difficult to decide whether to perform extensive tumour resection. Sometimes, however, the tumour develops rapidly threatening a number of functions or even the life of the patient.
With respect to both sporadic and familial paragangliomas, there is an urgent need of information about the growth kinetics, for definition of the indication, but also for the timing of surgical treatment. Such information is not provided by the histological features of the tumour (Lack et al., 1979) .
Flow cytometric analysis of the DNA content has revealed the widespread occurrence of DNA ploidy changes in human malignancies (Koss et al., 1989; Cornelisse & Tanke, 1990) .
Evidence pointing to an association between DNA aneuploidy and clinical aggressiveness in various types of solid tumour has been accumulating (Merkel & McGuire, 1990 ).
The aim of the present study was to find out whether DNA aneuploidy could be detected in paragangliomas as support for a neoplastic origin and, if so, whether this DNA aneuploidy is associated with the clinical extension of the tumour and can be used as a predictor of the growth rate. Furthermore, we were interested in finding out whether there were differences in DNA ploidy distribution between familial and sporadic tumours on the one hand and the ploidy distribution of multicentric tumours within the same patient or family on the other. The results indicate that DNA aneuploidy occurs relatively frequently in both familial and sporadic paragangliomas, but no correlations with clinical extension were found.
Materials and methods

Patients
During the past 32 years (Lack et al., 1979; Batsakis, 1982 For 20 skull-base tumours (GJTT), the tumour size and FCM were available. According to Rosenwasser (1973) The procedures used for cell preparation and the staining of fresh and paraffin-embedded tissue have been described elsewhere . Briefly, suspensions of isolated nuclei were prepared from fresh or frozen tissue specimens according to the detergent-trypsin procedure and stained with propidium iodide (PI) (Vindelov et al., 1983 The frequency distribution of DNA indices shows scattering between the diploid and tetraploid ranges (Figure 1) . Apart from the fact that more familial tumours were measured, there was no significant different in DNA index distribution between the familial and non-familial cases.
Individual patients belonging to the same family, showed no tendency to similarity in DNA ploidy pattern. Multicentricity was found predominantly in the familial group of 47 patients, 16 of whom had a double tumour (uni-or bilateral) and one even had three tumours. In the non-familial group (n = 30) only four patients had a double tumour. The DNA ploidy distribution in double tumours (Table II) showed that both tumours were DNA diploid or peridiploid in ten patients and that in three out of five patients with DNA (Figure 2 ). In the remaining patients the DNA stemlines of double tumours differed significantly.
DNA ploidy and clinical characteristics After subdivision according to tumour localisation in the head and neck (i.e. GJTT, VBT, CBT), no correlation was found between DNA ploidy and these localisations ( Table  Ib) . The average age at first diagnosis was available for 77 patients and was somewhat lower for the familial group, but this difference was not statistically significant. A correlation between DNA ploidy and the age at first diagnosis was not found. The mean age of the patients with DNA diploid tumours was 36 years and that of the peridiploid with elevated G2M phase and DNA aneuploid stemlines was 42 and 39 years, respectively (Table Ic) .
The average duration of symptoms was known for 73 patients. For the duration of symptoms there was a remarkable great difference between the minimum and maximum number of years recorded (Table Ic) . Irrespective of ploidy class, the average duration of symptoms amounted to about 3 years.
For 94 paragangliomas, DNA ploidy was analysed in relation to tumour size. However, the DNA ploidy distribution for small, intermediate, and large tumours did not differ significantly. When familial clustering was taken into account with respect to the average age at diagnosis, the duration of symptoms, and the size of the tumour, no significant differences were found.
Discussion
The results of this study show that aneuploid stemlines occur relatively frequently in clinically and histologically benign paragangliomas (37%), indicating that cytogenetically, these tumours represent true clonal proliferations. Although no definite proof, this strongly supports the neoplastic rather than the hyperplastic nature of these lesions as argued by some authors (Saldana et al., 1973; Arias-Stella & Valcarcel, 1973) . Similar results have recently been reported for a series of 13 carotid body tumours analysed with DNA-image cytometry by Barnes & Taylor (1990) who found abnormal DNA-histograms in 69% of the cases of which 15% were true aneuploid.
DNA aneuploidy has also been described for other benign tumours of neuro-endocrine origin. In a flow-cytometric study of pituitary adenomas done by Anniko et al. (1984) , aneuploidy was found in 49% of the cases, and Joensuu & Klemi (1988) reported aneuploidy for 29% of pituitary, 25% of thyroid, 26% of parathyroid, and 53% of adrenal adenomas without sign of invasive growth. Others have confirmed their findings (Joensuu & Klemi, 1988 , references cited therein, Schelfhout et al., 1990 . Thus, unlike colorectal adenomas, DNA aneuploidy in neuro-endocrine adenomas appears not be associated with a premalignant condition (van den Ingh et al., 1985) .
A correlation between DNA aneuploidy and the age of the patients with paragangliomas similar to that described by Joensuu & Klemi (1988) for other benign endocrine tumours was not found in the present study.
DNA ploidy distribution was not associated with familial clustering of the disease, which suggests that tumour-ploidy evolution did not differ essentially between the two categories of patients. In 13/21 (62%) of the patients with a double tumour, the two lesions had similar, predominantly (peri-) diploid, DNA indices (Table II) . With respect to the relatively low prevalence of DNA aneuploidy, the a priori probability of a combination of two (peri-)diploid stemlines is high. However, the observation that three out of five double tumours with DNA-aneuploid stemlines had closely similar DNA indices at first sight seems more puzzling. In one case (no. 107), the confluence of two tumour sites cannot be excluded. This does not hold for the other two patients (nos. 017, 048) who had bilateral tumours. In case no. 048 there is only a partial agreement since the hypodiploid stemline is lacking in the T2 tumour. Therefore, there is not enough evidence to suggest a non-random ploidy evolution of multicentric tumours in patients with hereditary disease even when a common, predisposing genetic condition can be assumed to be present. Such a 'programmed' ploidy evolution process, leading to identical karyotypes with the same specific and non-specific (secondary) chromosomal aberra- 1986, Sciallero et al., 1988; Shackney et al., 1989; Smit et al., 1990) . The relatively high proportion (15%) of peridiploid tumours with elevated G2M fraction compares with the 23% diploid-tetraploid tumours found in the series of Barnes and Taylor (1990) . This probably indicates a tendency of paragangliomas to develop genetically relatively stable tetraploid subpopulations which do not or only slowly progress to overt aneuploidy by chromosome loss.
Unlike the situation for several malignant tumours, no relationship was found between DNA ploidy and clinical signs of tumour progression.
Since the life expectancy of patients with paragangliomas does not differ significantly from that of the general population, we attempted to express tumour progression on the basis of parameters such as age at diagnosis, duration of symptoms, and size of the tumour. Since the introduction of CT scanning during the late seventies, it has been possible to make accurate and standardised estimations of tumour extension. In our retrospective study covering a period of 32 years, CT scans were not available for all of the patients and therefore paraganglioma size had to be classified semi-quantitatively, i.e. less objectively, particularly for skull-base tumours.
The absence of correlation between DNA ploidy and clinical signs of tumour progression indicates that at least at present, analysis of the DNA content is of no help in reaching a clinical decision as to whether or not extensive surgery should be performed in cases of young patients with paragangliomas. A similar conclusion was reached by Barnes and Taylor (1990) .
It remains an intriguing problem, that a variety of tumours of neuro-endocrine origin, including paragangliomas, can develop a quite pronounced DNA aneuploidy, that is indicative of numerical and probably also structural chromosomal aberrations, without showing overt signs of clinical malignancy. Recently, the presence of somatostatin receptors have been demonstrated in paragangliomas (Pauw et al., 1989) . The presence of these receptors in other neuro-endocrine tumours and breast tumours with neuro-endocrine characteristics appear to be associated with a differentiated type of tumour with rather low malignancy (Reubi & Torhorst, 1989 , references cited therein). One could hypothesise that the high somatostatin receptor content of paragangliomas may have some relationship with their usually indolent biological behaviour.
Lastly, our results show that in contrast with the situation for colorectal adenomas (Sciallero et al., 1988) , genetic predisposition does not lead to a higher incidence or more extensive development of aneuploidy in paragangliomas.
